Medicine recalls
|
| |
| Canada: Pharmascience Inc. voluntarily recalls one lot of pms-Atenolol 100mg due to a labelling error |
| |
Health Canada is advising that Pharmascience Inc. has initiated a voluntary recall of one lot of pms-Atenolol 100 mg, used to treat cardiovascular conditions such as hypertension (high blood pressure), due to a labelling error. The lot contains foil blister packs incorrectly labelled as pms-Atenolol 50 mg with the wrong Drug Identification Number (DIN). The information on the outer package is correct.
The labelling error could result in a patient taking a double dose of the product. This could result in excessively low blood pressure and decreased heart rate, particularly in elderly patients and patients with impaired kidney function, which may cause dizziness, fainting and falling. Other symptoms could include drowsiness, tiredness, nausea and diarrhea.
Product Affected : pms-Atenolol 100 mg
Lot Number : 495259
Expiry : May 31, 2017
Please refer to the following website in Health Canada for details:
http://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/../59716a-eng.php
In Hong Kong, pms-Atenolol Tablets 100mg (HK-61600) is a pharmaceutical product registered by Trenton-Boma Ltd (Trenton-Boma) in Hong Kong, and is a prescription-only medicine. According to Trenton-Boma, the affected batch (lot. no. 495259) has been imported into Hong Kong but not yet distributed into the market. The Department of Health has already instructed Trenton-Boma to withhold the product from distribution to the market.
Ends/Saturday, August 06, 2016
Issued at HKT 12:00
|
| |
